184 related articles for article (PubMed ID: 35027071)
21. Systemic therapy for endometrial stromal sarcomas: current treatment options.
Serkies K; Pawłowska E; Jassem J
Ginekol Pol; 2016; 87(8):594-7. PubMed ID: 27629136
[TBL] [Abstract][Full Text] [Related]
22. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment.
Beck TL; Singhal PK; Ehrenberg HM; Rose PG; Lele SB; Krivak TC; McBee WC
Gynecol Oncol; 2012 Apr; 125(1):141-4. PubMed ID: 22119993
[TBL] [Abstract][Full Text] [Related]
23. Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate?
Comert GK; Turkmen O; Kar I; Yucel O; Kilic C; Boran N; Basaran D; Karalok A; Turan T
J Chin Med Assoc; 2019 May; 82(5):385-389. PubMed ID: 31058712
[TBL] [Abstract][Full Text] [Related]
24. Endometrial stromal sarcoma arising from endometriosis: a clinicopathological study and literature review.
Lan C; Huang X; Lin S; Cai M; Liu J
Gynecol Obstet Invest; 2012; 74(4):288-97. PubMed ID: 22986788
[TBL] [Abstract][Full Text] [Related]
25. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
26. The clinical benefits of hormonal treatment for LG-ESS: a meta-analysis.
Cui R; Cao G; Bai H; Zhang Z
Arch Gynecol Obstet; 2019 Nov; 300(5):1167-1175. PubMed ID: 31583462
[TBL] [Abstract][Full Text] [Related]
27. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological characteristics and treatment strategies for patients with low-grade endometrial stromal sarcoma.
Cui R; Yuan F; Wang Y; Li X; Zhang Z; Bai H
Medicine (Baltimore); 2017 Apr; 96(15):e6584. PubMed ID: 28403089
[TBL] [Abstract][Full Text] [Related]
29. Primary gastric extra-uterine endometrial stromal sarcoma.
Jin M; Reynolds JP; Odronic SI; Wakely PE
Ann Diagn Pathol; 2014 Jun; 18(3):187-90. PubMed ID: 24636963
[TBL] [Abstract][Full Text] [Related]
30. Primary extrauterine endometrial stromal cell sarcoma: a case and review.
Zemlyak A; Hwang S; Chalas E; Pameijer CR
J Gastrointest Cancer; 2008; 39(1-4):104-6. PubMed ID: 19333789
[TBL] [Abstract][Full Text] [Related]
31. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?
Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M
J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.
Maeda O; Moritani S; Ichihara S; Inoue T; Ishihara Y; Yamamoto S; Ito M; Matsumura Y; Sugiyama K; Horio M; Kondo I
J Med Case Rep; 2015 Oct; 9():233. PubMed ID: 26481040
[TBL] [Abstract][Full Text] [Related]
33. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
34. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
35. Endometrial stromal sarcomas--a retrospective analysis of 11 patients.
Diesing D; Cordes T; Finas D; Löning M; Mayer K; Diedrich K; Friedrich M
Anticancer Res; 2006; 26(1B):655-61. PubMed ID: 16739335
[TBL] [Abstract][Full Text] [Related]
36. Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.
Malouf GG; Duclos J; Rey A; Duvillard P; Lazar V; Haie-Meder C; Balleyguier C; Morice P; Lhommé C; Pautier P
Ann Oncol; 2010 Oct; 21(10):2102-2106. PubMed ID: 20305035
[TBL] [Abstract][Full Text] [Related]
37. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases.
Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
Gynecol Oncol; 2008 Feb; 108(2):306-11. PubMed ID: 18061249
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.
Cade TJ; Quinn MA; Rome RM; Polyakov A
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561
[TBL] [Abstract][Full Text] [Related]
39. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
40. Low-grade endometrial stromal sarcoma: A Turkish uterine sarcoma group study analyzing prognostic factors and disease outcomes.
Ayhan A; Toptas T; Oz M; Vardar MA; Kayikcioglu F; Ozgul N; Gokcu M; Simsek T; Tunc M; Meydanli MM
Gynecol Oncol; 2021 Mar; 160(3):674-680. PubMed ID: 33375988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
